BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 28, 2005
View Archived Issues
NB-001 successfully completes phase II study in herpes labialis
Read More
CRADA for antiviral testing of Tarvacin
Read More
SC-236 attenuates colon tumor activity associated with cigarette smoking
Read More
First dual modulator of PGI2 and TXA2 shows promise as an antithrombotic agent
Read More
New class of intestinal Pi absorption inhibitor
Read More
Japanese Committee for Usage of Unapproved Drugs rules on Chugai drugs
Read More
Nonapprovable letter for Namenda for mild Alzheimer's disease
Read More
Vernalis completes acquisition of Ionix
Read More
Acambis' C. difficile vaccine begins phase I study
Read More
Phase III study of MyVax Personalized Immunotherapy cleared to continue
Read More
Tapestry to focus on development of TPI-287
Read More
U.K. phase I study of Reolysin begins enrollment
Read More
Ozarelix begins U.S. phase I/II trial for hormone-dependent prostate cancer
Read More
Adacel vaccine now available in U.S.
Read More
Novacea and Pierre Fabre partner on oral vinorelbine
Read More
Recent patents cover novel treatments for cognitive disorders
Read More
Trifunctional bispecific antibodies show promise in the treatment of cancer
Read More
Zegerid Chewable Tablets NDA accepted for filing
Read More
Blockade of melanocortin-4 receptors increases the potency of morphine
Read More
Novel anti-HIV agents reported by Panacos
Read More
NDA for indiplon tablets accepted for review
Read More
(-)-Gossypol induces apoptosis in cisplatin-resistant head and neck cancer cells
Read More
Salagen approved in Japan
Read More
Ruboxistaurin reduces vision loss risk in patients with diabetic retinopathy
Read More